SCHEMBL23166790

SCHEMBL23166790

Cc1cc(-c2ccccc2[N+](=O)[O-])ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ EIF4E P06730 2/20 0.54
▸ HSD17B10 Q99714 1/20 0.49
▸ HSD11B1 P28845 1/20 0.48
▸ MAPT P10636 3/20 0.44
▸ PTGS2 P35354 2/20 0.43
▸ NPBWR1 P48145 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ TSHR P16473 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MGAM O43451 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ SI P14410 1/20 0.41
▸ MGAM2 Q2M2H8 1/20 0.41
▸ DHFR P00374 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALPL P05186 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29962438 0.85 ALDH1A1 (0.59) TDP1ALDH1A1EIF4EHSD17B10HSD11B1
SCHEMBL1558204 0.85 ALDH1A1 (0.59) TDP1ALDH1A1EIF4EHSD17B10HSD11B1
SCHEMBL14797279 0.81 EIF4E (0.75) EIF4E
SCHEMBL23188582 0.79 TDP1 (0.56) TDP1ALDH1A1HSD17B10MAPTTSHR
SCHEMBL19320092 0.79 TDP1 (0.51) TDP1ALDH1A1EIF4EHSD17B10HSD11B1
SCHEMBL11633060 0.78 TDP1 (0.54) TDP1ALDH1A1HSD17B10MAPTTSHR
SCHEMBL15055251 0.76 ALDH1A1 (0.66) TDP1ALDH1A1HSD17B10MAPTMGAM
SCHEMBL1721464 0.76 ALDH1A1 (0.71) TDP1ALDH1A1EIF4EHSD17B10HSD11B1
SCHEMBL31903101 0.76 ALDH1A1 (0.71) TDP1ALDH1A1EIF4EHSD17B10HSD11B1
SCHEMBL17420850 0.76 ALDH1A1 (0.66) TDP1ALDH1A1HSD17B10MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384760-B2 Substituted carbazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2025-08-12 — — US disclosed
CN-114829350-B Substituted carbazole compounds 百时美施贵宝公司 2024-05-28 — — CN disclosed
US-20240076280-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2024-03-07 — — US disclosed
EP-4038059-B1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2023-09-20 — — EP disclosed
EP-4038059-A1 SUBSTITUTED CARBAZOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2022-08-10 — — EP disclosed
CN-114829350-A Substituted carbazole compounds 百时美施贵宝公司 2022-07-29 — — CN disclosed
WO-2021067657-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-04-08 — — WO disclosed
WO-2021067657-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240076280-A1 SUBSTITUTED CARBAZOLE COMPOUNDS TLR7, TLR3, TLR1 TDP1 1533/4885ALDH1A1 1776/4885EIF4E 2508/4885
US-12384760-B2 Substituted carbazole compounds TLR7, TLR3, TLR1 TDP1 1533/4885ALDH1A1 1776/4885EIF4E 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback